Strategic Vision Investment’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,000
Closed -$174K 17
2021
Q4
$174K Buy
+60,000
New +$173K 0.29% 14
2021
Q3
Sell
-60,000
Closed -$159K 24
2021
Q2
$159K Hold
60,000
0.09% 21
2021
Q1
$142K Hold
60,000
0.23% 12
2020
Q4
$131K Hold
60,000
0.05% 17
2020
Q3
$106K Hold
60,000
0.06% 17
2020
Q2
$82K Hold
60,000
0.04% 19
2020
Q1
$57K Hold
60,000
0.01% 15
2019
Q4
$92K Buy
+60,000
New +$84.6K 0.08% 11

Strategic Vision Investment's NFH.WS Position: Q1 2022 in Review

Strategic Vision Investment sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 60,000 shares — an estimated $174K sold.

Strategic Vision Investment first reported a position in NFH.WS in Q4 2019 and held it in 8 quarters. The position peaked at $174K in Q4 2021. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

  • Strategic Vision Investment reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
  • Strategic Vision Investment sold 60,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022, an estimated $174K.
  • Strategic Vision Investment first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 8 quarters.
  • Strategic Vision Investment's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $174K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on Strategic Vision Investment's 13F filing for Q1 2022, filed 12 May 2022.